Skip to main content
Clinical Trials/NCT01225016
NCT01225016WithdrawnNot Applicable

Characterization of Thyroid Nodules Using Contrast Enhanced Ultrasound

University of Alabama at Birmingham2 sites in 1 countryStarted: October 2010Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Withdrawn
Locations
2
Primary Endpoint
To estimate the accuracy (sensitivity and specificity) of the contrast enhanced ultrasound for characterization of thyroid nodules.

Study Overview

Brief Summary

This study will evaluate thyroid nodules using specialized ultrasound imaging methods.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
19 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients diagnosed with a thyroid nodule
  • Age greater than or equal to 19 years of age
  • Patients must sign informed consent

Exclusion Criteria

  • Women who are pregnant or nursing
  • Patients with pulmonary hypertension, unstable cardiopulmonary condition,or right to left shunt
  • Hypersensitivity to perfluten
  • Psychological condition that renders the patient unable to understand the informed consent

Outcomes

Primary Outcomes

To estimate the accuracy (sensitivity and specificity) of the contrast enhanced ultrasound for characterization of thyroid nodules.

Time Frame: 30 days

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Glenn Peters, MD

Professor of Surgery

University of Alabama at Birmingham

Study Sites (2)

Loading locations...

Similar Trials